In 1951, Henrietta Lacks was admitted at John Hopkins hospital for cervical cancer. Her cells were extracted from her tumour and cultured. They became the HeLa immortal cell line, a source of invaluable medical data to present day, used to develop the first Polio Vaccine, cell cloning and to study HIV. Despite this outstanding contribution to research, Henrietta never gave her consent. She died in poverty with no compensation or acknowledgement until present day.
We believe we have the right as patients to choose how our data is used for the common good. As digital health becomes the norm, this means changing the very organization of the Internet to reclaim control.
The promise of the Internet has been broken. Decentralization of information was meant to promote free speech, democratize knowledge, abolish censorship, expand services remotely… But the Internet is now centralized by a handful of platforms. They monetize our data as their own asset to make us better consumers, not more enlightened or healthier citizens at the expense of working and innovating for the common good. Our data is nothing less than our digital assets in the virtual world and the same way we own and are free to dispose of our assets in the real-world, we should own and dispose of our digital assets.
Our healthcare data is our most valuable digital asset: it can save our life in an emergency situation and provides critical decision-making information for the providers to offer us the best care. However, our records are held captive in protected silos for fear of being singled out, for fear of seeing our right to care violated. A wealth of digital data is lost to personalized medicine.
We want to become the steward of our health data, not having to rely on third parties to handle our most sensitive information. We have the right to break information silos, control where our data is stored, who has access to it, who we share it with. This power can dramatically affect how treatments are delivered, moving away from a top-down approach to an iterative process where we, patients, measure the effectiveness of more personalized treatments. This is a paradigm for medical research and change lives.
As third parties centralize our confidential data, unauthorized access becomes the norm. We, as patients, are kept out of the loop even in case of breaches. Decentralized ledgers let us enforce the security over our digital health assets, making tampering impossible, keeping track of violations in real-time, without no third party involved. Imagine we could still control our data even once it has been shared, removing access to enforce our privacy at any time.
Hospitals or pharmacies monetize our health data to pharmaceutical and insurance companies for marketing or pharmacovigilance studies. Even though there are strong benefits for using our data, we are not taking part in the sale of our own data. Blockchain will let us enforce our property. Smart contracts will let us set the terms by which others access our digital assets. Instead of being robbed of our data, we will willingly get involved and be compensated for our contribution to the development of innovative treatments.
Blockchain as a trust-generating technology is game-changing, destined to become the standard in industries that need trustworthy information without rent-seeking third parties. But its potential is shrouded by a wave of crypto-speculation that make the most solid projects look suspicious. To restore trust and allow news rights to come of age, we deliver real products with clear benefits, demonstrate financial transparency, and share our expertise to the healthcare ecosystem. We are working with regulators, health authorities, pharmaceutical companies, patient advocacy groups, care networks and providers to ensure patients, caregivers and researchers can reliably endorse the next generation of healthcare data.
Read why Real-World Data is becoming a key ingredient to bring precision medecine faster and to broader sets of patients,
In this explainer video, Embleema vows to fast-track research for rare diseases
Global Head of Evidence Generation at Sanofi Discusses the Benefits of Blockchain for Pharma
Harvard Professor John Halamka Discusses the Benefits of Blockchain in Healthcare
The deal will connect Armenia to international research, in oncology, immunotherapy and molecular medicine.
Embleema's Blockchain lets patient assemble their full health history and opt-in to research securely, and receive compensation for their active contribution
The digital health revolution has made it much easier for advocacy groups to begin leveraging patient data to fast-track research and engage pharma. Here's how to do it.
In the age of precision medicine, pharma must learn to collect data directly from patients, inventing new ways to secure their buy-in, in order to roll-out a successful real-world evidence strategy.
The FDA is exploring new sources of data to assess new drugs, including from Real World Evidence : EHR, wearables, Patient Reported Outcomes. Enter Blockchain
Joint Blockchain Initiative Set to Accelerate Cancer Research and define a new ethical model in drug development.
Embleema Closes $4M Series A Funding and Joins Techstars Alchemist Blockchain Accelerator Program
Pharmagest forms Partnership with Embleema to Deploy Innovative Healthcare Blockchain Technology
From Withings to Embleema, empowering patients with digital health
Startups like Embleema Want to Help Yo Sell It
Embleema launches the first health records blockchain to give patients complete control over their health data and be at the center of clinical research.
Le RGPD s et la blockchain seraient favorables aux start-up européennes